Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

3-Bromo-vortioxetine Hydrobromide

3-Bromo-vortioxetine Hydrobromide is listed under Impurity and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with vortioxetine. The product is supplied by Clearsynth under CAT No. CS-O-35928. Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.

Product Specifications

Overview

Useful research chemical for a range of applications.

CAS Number

2725536-51-4

Synonyms

3-Bromo-vortioxetine Hydrobromide

Molecular Formula

C 18 H 22 Br 2 N 2 S

Molecular Weight

458.25

Additionnal Information

3-Bromo-vortioxetine Hydrobromide is supplied with detailed characterization data compliant with regulatory guideline. 3-Bromo-vortioxetine Hydrobromide can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of vortioxetine.

Storage Conditions

Refer MSDS for complete information.

Applications Notes

Useful research chemical for a range of applications.

HSN Code

38229010

Hazard Compound

Refer MSDS for complete information.

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Rabbit Polyclonal GINS4 Antibody
TA590288 100 µg

Rabbit Polyclonal GINS4 Antibody

Sign In for Pricing
View Details
Human MDH1 ELISA KIT
EF000709 96 Tests

Human MDH1 ELISA KIT

Sign In for Pricing
View Details
UGT8 Antibody
orb2679267-01 50 µL

UGT8 Antibody

Sign In for Pricing
View Details
UGT8 Antibody
orb2679267-02 100 µL

UGT8 Antibody

Sign In for Pricing
View Details
UGT8 Antibody
orb2679267-03 200 µL

UGT8 Antibody

Sign In for Pricing
View Details
Anti-VEGFA (Vanucizumab)-MC-MMAF ADC
ADC-W-2290 1 mg

Anti-VEGFA (Vanucizumab)-MC-MMAF ADC

Sign In for Pricing
View Details